Boston Private Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Boston Private Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.28M	Sell	11,184 -507	-4%	-$55.9K	0.06%	217
2014 Q4	$1.18M	Buy	11,691 +561	+5%	+$54.5K	0.05%	222
2014 Q3	$1.01M	Buy	11,130 +525	+5%	+$46.1K	0.05%	232
2014 Q2	$909K	Sell	10,605 -450	-4%	-$35.5K	0.04%	243
2014 Q1	$871K	Sell	11,055 -45	-0.4%	-$3.75K	0.04%	246
2013 Q4	$840K	Buy	11,100 +2,160	+24%	+$153K	0.04%	250
2013 Q3	$625K	Buy	8,940 +390	+5%	+$25.6K	0.03%	259
2013 Q2	$496K	Buy	+8,550	New	+$494K	0.03%	271

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

BFA

Beaumont Financial Advisors Needham, Massachusetts $1.46B AUM 21.07% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Boston Private Bank & Trust's IBB Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its iShares Biotechnology ETF (IBB) stake by 4.3% in Q1 2015, selling an estimated $55.9K and leaving 11,184 shares worth $1.28M. The position accounts for 0.06% of the portfolio, ranked #217.

Boston Private Bank & Trust first reported a position in IBB in Q2 2013 and has held it in 8 quarters since. 400 funds tracked by Wall St. Rank hold IBB as of Q1 2015.

Boston Private Bank & Trust held 11,184 shares of iShares Biotechnology ETF worth $1.28M as of Q1 2015.
Boston Private Bank & Trust sold 507 iShares Biotechnology ETF shares in Q1 2015, an estimated $55.9K.
iShares Biotechnology ETF made up 0.06% of Boston Private Bank & Trust's portfolio in Q1 2015, its #217 holding.
Boston Private Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 8 quarters since.
400 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.